aztreonam has been researched along with Clostridium Infections in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Clostridium Infections: Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with a beta-lactam allergy label (BLAL) were found to have decreased utilization of beta-lactams (p < ." | 1.72 | Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients. ( Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motzer, AR | 1 |
| Holaday, E | 1 |
| Axelrod, P | 1 |
| Mishkin, A | 1 |
1 other study available for aztreonam and Clostridium Infections
| Article | Year |
|---|---|
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infect | 2022 |